Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Mitochon Pharmaceuticals

Mitochon Pharmaceuticals
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE
$300K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of mitochondrial targeted compounds designed to bring forward meaningful drugs that work at the root of insidious diseases. The company's mitochondrial targeted compounds are used in the treatments for insidious diseases through the modulation of mitochondrial physiology, with applications to neurodegeneration, neuromuscular and developmental diseases, providing consumers with treatments from the power of the mitochondria to provide broad neural protection against diseases including Huntington's, Multiple Sclerosis, Epilepsy, Autism, Rett Syndrome, Batten Disease, Stroke, Duchenne Muscular Dystrophy (DMD), Alzheimer's Disease, Parkinson Disease and severe burns.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 259 Radnor Chester Road
  • Suite 210
  • Radnor, PA 19087
  • United States

+1 (215) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Mitochon Pharmaceuticals’s full profile, request a free trial.

Mitochon Pharmaceuticals Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 21-Dec-2017 $300K 00.000 Completed Pre-Clinical Trials
3. Grant 03-Oct-2017 000 00.000 Completed Pre-Clinical Trials
2. Convertible Debt 17-May-2016 $1.6M $2.35M Completed Startup
1. Convertible Debt 31-Mar-2015 $750K $750K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Mitochon Pharmaceuticals Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Michael J. Fox Foundation Limited Partner 000 0000 000000 0
Ben Franklin Technology Partners of Southeastern Pennsylvania Venture Capital Minority 000 0000 000000 0
YT Angels Other Minority 000 0000 000000 0

Mitochon Pharmaceuticals Executive Team (5)

Name Title Board
Seat
Contact
Info
Robert Alonso Co-Founder, President & Chief Executive Officer
John Geisler Ph.D Co-Founder & Chief Scientific Officer
Peter Crooks Ph.D Senior Vice President, Chemistry (Part Time)

2 Former Executives

You’re viewing 3 of 5 executives. Get the full list »